A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Jul 2018
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 09 Jul 2018 Planned End Date changed from 15 Nov 2019 to 12 Nov 2019.
- 09 Jul 2018 Planned primary completion date changed from 15 Nov 2019 to 12 Nov 2019.
- 09 Jul 2018 Status changed from recruiting to active, no longer recruiting.